Literature DB >> 29865073

Pathological Correlates of Cognitive Impairment in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age.

Andrew C Robinson1, Yvonne S Davidson1, Michael A Horan1, Neil Pendleton1, David M A Mann1.   

Abstract

The neuropathological changes responsible for cognitive impairment and dementia remain incompletely understood. Longitudinal studies with a brain donation end point allow the opportunity to examine relationships between cognitive status and neuropathology. We report on the first 97 participants coming to autopsy with sufficient clinical information from The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age. This study began in 1983 and recruited 6,542 healthy individuals between 1983 and 1994, 312 of whom consented to brain donation. Alzheimer-type pathology was common throughout the cohort and generally correlated well with cognitive status. However, there was some overlap between cognitive status and measures of Alzheimer pathology with 26% of cognitively intact participants reaching either CERAD B or C, 11% reaching Thal phase 4 or 5, and 29% reaching Braak stage III- VI. Cerebral amyloid angiopathy(CAA), α-synuclein, and TDP-43 pathology was less common, but when present correlated well with cognitive status. Possession of APOEɛ4 allele(s) was associated with more severe Alzheimer-type and CAA pathology and earlier death, whereas possession of APOEɛ2 allele(s) had no effect on pathology but was more common in cognitively intact individuals. The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age cohort is pathologically representative when compared with similar studies. Cognitive impairment in life correlates strongly with all pathologies examined and the APOE status of an individual can affect pathology severity and longevity.

Entities:  

Keywords:  APOE; Alpha-synuclein; Alzheimer’s disease; cognitivezzm321990dysfunction; cohort studies; dementia; longitudinal studies; neuropathology

Mesh:

Substances:

Year:  2018        PMID: 29865073     DOI: 10.3233/JAD-180171

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals.

Authors:  Alexandra M Wennberg; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Mary M Machulda; Leonard Petrucelli; Michelle M Mielke; Clifford R Jack; David S Knopman; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2019-01-21       Impact factor: 4.673

2.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Authors:  Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; Helena C Chui; David W Fardo; Margaret E Flanagan; Glenda Halliday; Suvi R K Hokkanen; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Shigeo Murayama; Melissa E Murray; Sukriti Nag; Robert A Rissman; William W Seeley; Reisa A Sperling; Charles L White; Lei Yu; Julie A Schneider
Journal:  Brain       Date:  2019-06-01       Impact factor: 15.255

3.  No association between head injury with loss of consciousness and Alzheimer disease pathology-Findings from the University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age.

Authors:  Andrew C Robinson; Yvonne S Davidson; Michael A Horan; Maggie Cairns; Neil Pendleton; David M A Mann
Journal:  Int J Geriatr Psychiatry       Date:  2019-05-10       Impact factor: 3.485

4.  Influence of APOE Genotype on Mortality and Cognitive Impairment.

Authors:  Andrew C Robinson; Yvonne S Davidson; Federico Roncaroli; James Minshull; Phillip Tinkler; Michael A Horan; Antony Payton; Neil Pendleton; David M A Mann
Journal:  J Alzheimers Dis Rep       Date:  2020-07-23

5.  Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease.

Authors:  Stefan J Teipel; H-Christian Fritz; Michel J Grothe
Journal:  Neurology       Date:  2020-07-06       Impact factor: 9.910

6.  Influence of APOE genotype in primary age-related tauopathy.

Authors:  Andrew C Robinson; Yvonne S Davidson; Federico Roncaroli; James Minshull; Phillip Tinkler; Michael A Horan; Antony Payton; Neil Pendleton; David M A Mann
Journal:  Acta Neuropathol Commun       Date:  2020-12-07       Impact factor: 7.801

7.  A Comparative Study of Pathological Outcomes in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age and Brains for Dementia Research Cohorts.

Authors:  Andrew C Robinson; Stephen Chew-Graham; Yvonne S Davidson; Michael A Horan; Federico Roncaroli; James Minshull; Daniel du Plessis; Piyali Pal; Antony Payton; Neil Pendleton; David M A Mann
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

8.  Mid to late-life scores of depression in the cognitively healthy are associated with cognitive status and Alzheimer's disease pathology at death.

Authors:  Andrew C Robinson; Federico Roncaroli; Yvonne S Davidson; James Minshull; Calvin Heal; Daniela Montaldi; Antony Payton; Michael A Horan; Neil Pendleton; David M A Mann
Journal:  Int J Geriatr Psychiatry       Date:  2020-11-20       Impact factor: 3.485

9.  Superior Frontal Gyrus TOMM40-APOE Locus DNA Methylation in Alzheimer's Disease.

Authors:  Natalia Bezuch; Steven Bradburn; Andrew C Robinson; Neil Pendleton; Antony Payton; Chris Murgatroyd
Journal:  J Alzheimers Dis Rep       Date:  2021-04-06

10.  Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study.

Authors:  Adam J Dugan; Peter T Nelson; Yuriko Katsumata; Lincoln M P Shade; Kevin L Boehme; Merilee A Teylan; Matthew D Cykowski; Shubhabrata Mukherjee; John S K Kauwe; Timothy J Hohman; Julie A Schneider; David W Fardo
Journal:  Acta Neuropathol Commun       Date:  2021-09-15       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.